Covid: UK first country to approve dual-strain vaccine
The UK has become the first country to approve a dual vaccine which tackles both the original Covid virus and the newer Omicron variant.
Ministers say the vaccine will now form part of the autumn booster campaign.
Moderna thinks 13 million doses of its new vaccine will be available this year, but 26 million people are eligible for some form of booster.
Health officials say people should take whichever booster they are offered as all jabs provide protection.
Moderna's latest vaccine - called Spikevax - targets both the original strain and the first Omicron variant (BA.1), which emerged last winter. It is known as a bivalent vaccine as it takes aim at two forms of Covid.
The UK's Medicines and Healthcare Products Regulatory Agency has considered the evidence and given the vaccine approval for use in adults.
Dr June Raine, the regulator's chief executive, said: "What this bivalent vaccine gives us is a sharpened tool in our armoury to help protect us against this disease as the virus continues to evolve."
Source: BBC News, 16 August 2022